Quigley Jill M.
- SEC CIK
- 0001799780
In the past year, 1 open-market sale filing worth $441.4K and no purchases.
Current role at each company
- TERN Terns Pharmaceuticals, Inc.Directoras of May 5, 2026
- CMMB Chemomab Therapeutics Ltd.Directoras of Jun 20, 2023
- PASG Passage BIO, Inc.Chief Operating Officeras of Dec 10, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $441.4K
- 1 filing
- Net
- −$441.4K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Quigley Jill M. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TERN Terns Pharmaceuticals, Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 17, 2024 (view filing) | Jul 15-16 | 2 days | Quigley Jill M.Director | SSale | −14.8K | $10.00 | −$147.7K | −33.0%30.0K after | 2 lots10b5-1 |
| Aug 5, 2024 (view filing) | Aug 1-2 | 4 days | Quigley Jill M.Director | SSale | −15.0K | $7.57 | −$113.6K | −50.0%15.0K after | 2 lots10b5-1 |
| Sep 11, 2024 (view filing) | Sep 9 | 2 days | Quigley Jill M.Director | SSale | −17.2K | $10.00 | −$172.3K | −53.5%15.0K after | 10b5-1 |
| Jan 6, 2025 (view filing) | Jan 2-6 | 4 days | Quigley Jill M.Director | SSale | −15.0K | $5.76 | −$86.4K | −100.0%0 after | 2 lots10b5-1 |
| Nov 5, 2025 (view filing) | Nov 4 | 1 day | Quigley Jill M.Director | SSale | −24.5K | $18.00 | −$441.4K | −100.0%0 after | 10b5-1 |